ID
14817
Beschrijving
A Clinical Trial to Study the Effects of Nanoparticle Based Paclitaxel Drug, Which Does Not Contain the Solvent Cremophor, in Advanced Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00915369
Link
https://clinicaltrials.gov/show/NCT00915369
Trefwoorden
Versies (1)
- 29-04-16 29-04-16 -
Geüploaded op
29 april 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Advanced Breast Cancer NCT00915369
Eligibility Advanced Breast Cancer NCT00915369
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
er/pr positive status
Datatype
boolean
Alias
- UMLS CUI [1]
- C1719706
- UMLS CUI [2]
- C0069515
Beschrijving
her2+ detected with fish/cis
Datatype
boolean
Alias
- UMLS CUI [1]
- C2316574
Beschrijving
hypersensitivity to paclitaxel or any other taxane
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0020517
- UMLS CUI [1,2]
- C0215136
Beschrijving
chemotherapy, hormonal therapy immunotherapy, therapy with biologicals or radiotherapy
Datatype
boolean
Alias
- UMLS CUI [1]
- C0392920
- UMLS CUI [2]
- C0021083
Beschrijving
cns lesions
Datatype
boolean
Alias
- UMLS CUI [1]
- C0742468
Similar models
Eligibility Advanced Breast Cancer NCT00915369
- StudyEvent: Eligibility
C0205269 (UMLS CUI [1,2])
C0069515 (UMLS CUI [2])
C0215136 (UMLS CUI [1,2])
C0021083 (UMLS CUI [2])